Learn about rheumatoid vasculitis, neutrophilic dermatoses, and other rheumatoid arthritis rashes, their symptoms, and when ...

High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.

Worries that tumor necrosis factor (TNF) inhibitors may exacerbate or even cause lung disease in patients with rheumatoid ...

GLP-1 RA drugs help treat diabetes by weight loss, improving blood glucose levels and increasing insulin sensitivity, low ...

Nurse-led care effectively reduces disease activity and improves self-efficacy in patients with rheumatoid arthritis, ...

RA treatment aims to decrease inflammation, which decreases symptoms (pain/discomfort and stiffness), and lessens the risk of joint damage. By limiting joint damage, disability is reduced. The primary ...

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

The results also showed that the patients taking the GLP-1 RA drugs have a 12 per cent lower risk of hospital re-admission ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...

Study to determine which treatments best for which inflammatory arthritis patients should result in patients being better ...

Timely escalation to second-line disease-modifying drugs after treat-to-target methotrexate failure may not prevent the development of difficult-to-treat rheumatoid arthritis. Early treatment ...